| FRANKLIN ATHENA UNCORRELATED STRATEGIES UCITS FUND P2 (ACC) USD | RENT. ABSOLUTA. | 12,527864 | 20/10/2026 | 14,73% | · | ND |
| FRANKLIN ATHENA UNCORRELATED STRATEGIES UCITS FUND P2-H1 (ACC) EUR | RENT. ABSOLUTA. | 12,770000 | 20/10/2026 | 8,13% | · | ND |
| FRANKLIN ATHENA UNCORRELATED STRATEGIES UCITS FUND W (ACC) USD | RENT. ABSOLUTA. | 11,555952 | 20/10/2026 | 14,39% | · | ND |
| FRANKLIN BIOTECHNOLOGY DISCOVERY A (ACC) CHF-H1 | RVI BIOTECNOLOGÍA | 24,596731 | 20/10/2026 | 4,28% | 80,03% | **** |
| FRANKLIN BIOTECHNOLOGY DISCOVERY A (ACC) EUR-H1 | RVI BIOTECNOLOGÍA | 17,720000 | 20/10/2026 | 5,41% | 89,32% | ***** |
| FRANKLIN BIOTECHNOLOGY DISCOVERY A (ACC) HKD | RVI BIOTECNOLOGÍA | 4,730582 | 20/10/2026 | 12,47% | 89,80% | ***** |
| FRANKLIN BIOTECHNOLOGY DISCOVERY A (ACC) SGD | RVI BIOTECNOLOGÍA | 41,316781 | 20/10/2026 | 12,39% | 89,63% | **** |
| FRANKLIN BIOTECHNOLOGY DISCOVERY A (ACC) USD | RVI BIOTECNOLOGÍA | 56,763263 | 20/10/2026 | 12,44% | 89,89% | ***** |
| FRANKLIN BIOTECHNOLOGY DISCOVERY I (ACC) EUR-H1 | RVI BIOTECNOLOGÍA | 37,260000 | 20/10/2026 | 6,09% | 94,06% | ***** |
| FRANKLIN BIOTECHNOLOGY DISCOVERY I (ACC) USD | RVI BIOTECNOLOGÍA | 92,117700 | 20/10/2026 | 13,22% | 94,81% | ***** |
